About Us
Research groups
Friends
Back to research groups
Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland, since March 2022. He was group leader at the Hubrecht Institute from 2002 until March 2022 and currently he is advisor/guest researcher at the Hubrecht Institute.
The Organoid group, previously Clevers group, studies the molecular mechanisms of tissue development and cancer of various organs using organoids made from adult Lgr5 stem cells.
Tcf as Wnt effector In 1991, we reported the cloning of a T cell specific transcription factor that we termed TCF1 (1). Related genes exist in genomes throughout the animal kingdom. We have shown in frogs (4), flies (7) and worms (11) that the TCF proteins constitute the effectors of the canonical Wnt pathway. Upon Wnt signaling, ß-catenin binds and activates nuclear TCFs by providing a trans-activation domain. For these studies, we designed the widely used pTOPFLASH Wnt reporters. In the absence of Wnt signaling, we found that Tcf factors associate with proteins of the Groucho family of transcriptional repressors to repress target gene transcription (9).
Wnt signaling in cancer The tumor suppressor protein APC forms the core of a cytoplasmic complex which binds ß-catenin and targets it for degradation in the proteasome. In APC-deficient colon carcinoma cells, we demonstrated that ß-catenin accumulates and is constitutively complexed with the TCF family member TCF4, providing a molecular explanation for the initiation of colon cancer (5).
Wnt signaling in adult stem cells
In mammals, physiological Wnt signaling is intimately involved with the biology of adult stem cells and self-renewing tissues (18,19). We were the first to link Wnt signaling with adult stem cell biology, when we showed that TCF4 gene disruption leads to the abolition of crypts of the small intestine (8), and that TCF1 gene knockout severely disables the stem cell compartment of the thymus (2). The Tcf4-driven target gene program in colorectal cancer cells is the malignant counterpart of a physiological gene program in selfrenewing crypts (13, 14).
Lgr5 as adult stem cell marker
Amongst the intestinal Wnt target genes (13), we found the Gpr49/Lgr5 gene to be unique in that it marks small cycling cells at crypt bottoms. These cells represent the epithelial stem cells of the small intestine and colon (23), the hair follicle (24), the stomach (28) and many other tissue stem cell types. The cells also represent the cells-of-origin of adenomas in the gut (25) and within adenomas Lgr5 stem cells act as adenoma stem cells (36). Lgr6 marks multipotent skin stem cells (29).
Lgr5 stem cell biology
The Wnt target gene encoding the transcription factor Achaete scute-like 2 controls intestinal stem cell state (26). Lgr5 crypt stem cells behave in unanticipated ways: Against common belief, they divide constantly and in a symmetric fashion. Stem cells numbers remain fixed because stem cells compete ‘neutrally’ for niche space (30). This phenomenon was confirmed by in vivo imaging (44). Daughters of the small intestinal stem cells, the Paneth cells, serve as crypt niche cells by providing Wnt, Notch and EGF signals (33). The transcriptional hierarchy of the various enteroendocrine lineages was mapped in mouse and man (58, 66).
Lgr5 is the R-spondin receptor
Lgr5 resides in Wnt receptor complexes and mediates signaling of the Wnt-agonistic R-spondins (31), explaining the unique dependence of Lgr5 stem cells on secreted R-spondins in vivo and in vitro. Two other Wnt target genes, RNF43 and ZNRF3, encode stem cell-specific E3 ligases that downregulate Wnt receptors in a negative feedback loop (35). Independent work by the Feng Cong lab has first shown that R-spondin, when bound to Lgr5, captures and inactivates RNF43/ZNRF3.
Long-term clonal culturing of organoids from Lgr5 stem cells. Modeling of infectious, hereditary disease and cancer in organoids (reviewed in 51)
Wnt signaling intimately interacts with the BMP and Notch cascades to drive proliferation and inhibit differentiation in intestinal crypts and adenomas (17, 20). Based on these combined insights, we have established Lgr5/R-spondin-based culture systems that allow the outgrowth of single mouse or human Lgr5 stem cells into ever-expanding organoids. Some examples are mini-guts (27, 32), mini-stomachs (28), colon cancer organoids (32, 47), liver organoids (39, 46, 55), prostate organoids (45), breast cancer organoids (53), ovarian cancer organoids (59), pancreas cancer organoids (48), and even snake venom gland organoids (61). These epithelial organoid cultures are genetically and phenotypically extremely stable, allowing transplantation of the cultured offspring of a single stem cell, as well as disease modeling by growing organoids directly from diseased patient tissues (32, 47, 53). The direct cloning of multiple individual cells from primary tumors allows molecular and functional analysis of tumor heterogeneity with unprecedented resolution (54).
Human organoids allow functional analyses of rare cell types, such as enteroendocrine cells (66). They are readily amenable to CRISPR-mediated genome modification to model for instance malignant transformation (49) and mutagenesis upon faulty DNA repair (52), or to rapidly create knock-in alleles of genes of interest (62, 66). Human rectal organoids model the hereditary disease Cystic Fibrosis, are now routinely used to predict drug response in CF patients. In 2013, we have provided the first proof-of-concept for CRISPR-mediated repair of a hereditary mutation in patient stem cells (43, 64). Human organoids also model infectious disease, as demonstrated for instance for Cryptosporidium (55), a mutagenic E. coli strain (63) and for SARS-CoV-2 (65).
In sum, stem cell-derived organoids (as first described by Sasai for pluripotent stem cells and by us for adult stem cells) are rapidly gaining ground as research tools in a wide range of scientific disciplines including basic developmental and cell biology, infectiology, toxicology and research on hereditary diseases and cancer.
In this video, Hans Clevers summarizes the use of organoids in cancer research.
Selected papers (out of ~780 peer-reviewed papers with ~160,000 citations in Scopus; h-index 193)
Bannier-Hélaouët M, Korving J, Ma Z, Begthel H, [...] Wu W, Clevers H
Download|2024
Hendriks D, Pagliaro A, Andreatta F, Ma Z [...] Clevers H, Artegiani B
Dayton T, Alcala N, Moonen L, Den Hartigh L [...] Fernández-Cuesta L, Clevers H
Download|2023
Millen R, De Kort WWB, Koomen M, Van Son GJF [...] Driehuis E, Clevers H
Lin L, Demartino, J, Wang, D, Van Son, GJF [...] Van Es J, Clevers H
Hendriks D, Brouwers JF, Hamer K, Geurts MH, […] Artegiani B, Clevers H
He GW, Lin L, DeMartino J, Zheng X, Staliarova N, [...] Holstege F, Clevers H
Download|2022
Lohmussaar K, Oka R, Espejo Valle-Inclan J, Veersema S, [...] van Boxtel R, Clevers H
Download|2021
Bannier-Hélaouët M, Post Y, Korving J [...] Imhoff S, Clevers H
Lamers MM, Beumer J, van der Vaart J [...] Haagmans, BL, Clevers H
Download|2020
Post Y, Puschhof J, Beumer B [...] Casewell NR, Clevers H
Beumer J, Puschhof J, Bauzá-Martinez [...] Wu, W and Clevers H
Artegiani B, Hendriks D, Beumer J [...] Tans, S and Clevers, H
Geurts, MH de Poel E, Amatngalim, GD [...}, Beekman, JM and Clevers, H
Pleguezuelos-Manzano C, Puschhof J, Rosendahl A [...] van Boxtel R, Clevers H
Kopper O, de Witte, CJ [...] Kloosterman WP, Clevers H
Download|2019
Schutgens F, Rookmaaker MB [...] Verhaar MC, Clevers H
Gehart H, van Es J, [...] Rios A, and Clevers H
Hu H, Gehart H [...] de Jong YP, Clevers H
Download|2018
Roerink SF, Sasaki N [...] Stratton MR, Clevers H
Sachs N, de Ligt J [...] Cuppen E, Clevers H
EU-Organoid-67013
Drost J, van Boxtel R [...] Cuppen E, Clevers H
Download|20171013
Clevers, H.
Download|20160501
Drost, J, van Jaarsveld, R.H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A.,Sachs, N., Overmeer, R.M., Offerhaus, G.J., Begthel, H. Korving, J., van de Wetering, M., Schwank, G. Logtenberg, M., Cuppen, E., Snippert, H.J., Medema, J.P., Kops, G. J. P. L., Clevers, H.
Download|20150501
Farin, H.F., Jordens, I., Mosa, M.H., Basak, O., Korving, J., Tauriello, D.V.F., de Punder, K., Angers, S., Peters, P.J. Maurice, M.M. and Clevers, H.
van de Wetering, M., Francies, H.E., Francis, J.M., Bounova, G., Iorio, F., Pronk, A., ... Garnett, M.J., Clevers, H.
Boj, S.F., Hwang, C.I., Baker, L.A., Chio, I.I., Engle, D.D., ..., Clevers, H, Tuveson, D.A.
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.A., Ellis, E., van Wenum, M., Fuchs, S., de Ligt, S., van de Wetering, M., Sasaki, N., Boers, S.J., Kemperman, H., de Jonge, J., Ijzermans, J.N.M., Niewenhuis, E.E.S., Hoekstra, R., Strom, S., Vries, R.G.J., van der Laan, L.J.W., Cuppen, E., Clevers, H.
Karthaus, W.R., Iaquinta, P.J., Drost, J., Gracanin, A.., van Boxtel, R., Wongvipat, J., Dowling, C.M., Gao, D., Begthel, H., Sachs, N., Vries, R.G., Cuppen, E., Chen, Y., Sawyers, C.L., Clevers, H.
Download|20140501
Ritsma, L., Ellenbroek, S.I., Zomer, A., Snippert, H.J., de Sauvage, F.J., Simons, B.D., Clevers, H., van Rheenen, J.
Schwank, G., Koo, B.K., Sasselli, V., Dekkers, J.F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C.K., Nieuwenhuis, E.E., Beekman, J.M. and Clevers, H.
Download|20130501
Stange, D.E., Koo, B.K., Huch, M., Sibbel, G., Basak, O., Lyubimova, A.,Kujalla, P., Bartfeld, S., Koster, J., Geahlen, J.H., Peters, P.J., van Es, J., van de Wetering, M., Mills, J.C., Clevers, H.
Sato, T., Clevers, H.
Huch M., Dorell, C., Boj, S.F., van Es, J.H., van de Wetering, M., Li, V.S.W., Hamer, K., Sasaki, N., Finegold, M.J., Haft, A., Grompe, M., Clevers, H.
Boj, S,F., van Es, J.H.,Huch. M., Li, V.S., Jose, A., Hatzis, P., Mokry, M., Haegebarth, A., van den Born, M., Chambon, P., Voshol, P., Dor, Y., Cuppenm E., Fillat, C., Clevers, H.
Download|20120501
van Es, J.H., Sato, T., van de Wetering, M., Lyubimova, A., Yee Nee, A.N., Gregorieff, A., Sasaki, N., Zeinstra, L., van de Born, M., Korving, J., Martens, A.C., Barker, N., van Oudenaarden, A., Clevers, H.
Schepers, A.G., Snippert, H.J., Stange, D.E., van den Born, M., van Es, J.H., van de Wetering, M., Clevers, H.
Koo, B-K., Spit, M. Jordens, I., Low, T.Y., Stange, D.E., van de Wetering, M., van Es, J.H., Mohammed, S., Heck, A.J.R., Maurice, M.M. and Clevers, H.
de Lau, W., Barker, N., … and Clevers, H.
Download|20110501
Li, V.S., Ng, S.S., Boersema, P.J., Low, T.Y., Karthaus, W.R., Gerlach, J.P., Mohammed, S., Heck, A.J., Maurice, M.M., Mahmoudi, T. and Clevers, H.
Snippert, .J., van der Flier, L.G., Sato, T., van Es, J.H., van den Born, M., Kroon-Veenboer, C., Barker, N.,Klein, A.M., van Rheenen, J. Benjamin D. Simons, B.D. and Clevers, H.
Download|20100501
Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born, M., Barker, N., Shroyer, N.F., van de Wetering, M., Clevers, H.
Snippert, H.J., Haegebarth, A., Kasper, M., Jaks, V., van Es, J.H., Barker, N., van de Wetering, M., van den Born, M., Begthel, H., Vries, R.G., Stange, D.E., Toftgård, R., Clevers, H.
Barker, N, Huch, M., …, and Clevers, H.
Sato, T., Vries, R., Snippert, H., van de Wetering, M., Barker, N., Stange, D., van Es, J., Abo, A., Kujala, P., Peters, P., and Clevers, H.
Download|20090501
van der Flier, L.G., van Gijn, M.E., .., and Clevers, H.
Barker N., Ridgway R.A., van Es J.H.,van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers, H.
Jaks V., Barker N., Kasper M., van Es J.H., Snippert H.J., Clevers H., Toftgård, R.
Download|20080501
Barker, N, van Es, J.H., Kuipers, J., Kujala P., van den Born, M., Cozijnsen, M., Korving, J., Begthel, H., Peters, P.C., and Clevers, H.
Download|20070501
Download|20060501
Batlle E., Bacani J., Begthel H., Jonkheer S., Gregorieff A., Van de Born M., Malats N., Sancho E., Boon E., Pawson T., Gallinger S., Pals S., Clevers, H.
Download|20050501
Van Es J.H., Van Gijn M.E., Riccio O., Van den Born M., Vooijs M., Begthel H., Cozijnsen M., Robine S., Winton D.J., Radtke F., Clevers, H.
Reya T., Clevers H.
Radtke, F and Clevers, H.
Haramis A.P., Begthel H., van den Born M., van Es J., Jonkheer S., Offerhaus G.J., Clevers H.
Download|20040501
Baas A.F., Kuipers J., van der Wel N.N., Batlle E., Koerten H.K., Peters P.J., Clevers H.C.
Hurlstone A.F., Haramis A.P., Wienholds E., Begthel H., Korving J., Van Eeden F., Cuppen E., Zivkovic D., Plasterk R.H., Clevers H.
Download|20030501
Battle, E., Henderson, J.T., Beghtel, H., van den Born, M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., Clevers, H.
Download|20020501
Van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., Van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A-P., Tjon-Pon-Fong, M., Moerer, P., Van den Born, M., Soete, G., Pals, S., Eilers, M., Medema, R., Clevers, H.
Bienz, M., and Clevers, H.
Download|20000501
Korswagen, R., Herman, M. and Clevers, H.
Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., Goldschmeding, R., Logtenberg, T., and Clevers, H.
Download|19990501
Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., van de Wetering, M., Destree, O., and Clevers, H.
Download|19980501
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P.J. and Clevers, H.
Van de Wetering, M., Cavallo, R., Dooijes, D., Van Beest, M., Van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H.
Download|19970501
Morin, P.J., Sparks, A., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K.
Korinek, V, Barker, N., Morin, P.J., van Wichen, D., de Weger, R., Kinzler, K.W., Vogelstein, B., and Clevers, H.
Molenaar, M., Van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O. And Clevers, H.
Download|19960501
Schilham, M., Oosterwegel, M., Moerer, P., Jing Ya, de Boer, P., van de Wetering, M., Verbeek, S., S., Lamers, W., Kruisbeek, A., Cumano, A., and Clevers, H .
Verbeek, J.S., Ison, D., Hofhuis, F., Robanus-Maandag, E., te Riele, H., van de Wetering, M., Oosterwegel, M., Wilson, A., MacDonald, H.R. and Clevers, H.C.
Download|19950501
van de Wetering, M., Oosterwegel, M., Dooijes, D., and Clevers, H.C
Download|19910501
The Organoid group, previously Clevers group, studies the biology of Wnt signaling in tissue turnover and in cancer. The discovery of Lgr5 as a generic marker of Wnt-dependent stem cells within multiple adult tissues has led to the development of technology to grow these stem cells into ever-expanding epithelial organoids. These organoids recapitulate many aspects of their tissue of origin and allow the study of a multitude of physiological and pathological processes. Patient-derived organoids hold promise to predict drug response in a personalized fashion and open up new avenues for regenerative medicine and, in combination with genome editing technology, for gene therapy.
Scientific training and positions
1985 – 1989 Postdoctoral Fellow, Cox Terhorst Lab at the Dana-Farber Cancer Institute, Boston MA, USA 1989 – 1991 Assistant Professor, Department of Clinical Immunology, University of Utrecht 1991 – 2002 Professor and Chairman, Dept. of Immunology, Faculty of Medicine, University of Utrecht 2002 – 2012 Director Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences 2002 – 2020 Professor in Molecular Genetics at University Medical Center Utrecht 2002 – 2022 Principal Investigator of a research group of ~40 scientists at Hubrecht Institute, Utrecht. 2022 – Guest Scientist/Advisor of Organoid research group at Hubrecht Institute, Utrecht. 2012 – 2015 President of the Royal Netherlands Academy of Sciences (KNAW), Amsterdam 2014 – 2020 Chief Scientific Officer of HUB Organoids Technology, Utrecht 2015 – 2019 Chief Scientific Officer/Director Research of the Princess Máxima Center, Utrecht 2015 – 2022 Principal Investigator at the Princess Máxima Center, Utrecht. 2022 – Guest Scientist/Advisor of Organoid research group at the Princess Máxima Center, Utrecht. 2017 – Oncode Investigator 2020 – Professor of Molecular Genetics at University Utrecht 2022 – Head of Pharma, Research and Early Development (pRED) and Member of the – Enlarged Executive Committee of F. Hoffmann-La Roche Ltd, Basel, Switzerland
Read less
Awards
2000 Catharijne prize for medical research 2001 Award from the European Society for Clinical Investigation 2001 Spinoza Award of the Netherlands Research Council (NWO) 2004 Louis-Jeantet Prize for Medicine, Geneva, Switzerland 2005 The Science and Society Prize, Amsterdam 2005 The French honor of “Chevalier de la Legion d’Honneur” 2005 Katharine Berkan Judd Award, New York 2006 Rabbi Shai Shacknai Memorial Prize for Immunology and Cancer Research, Jerusalem 2008 Josephine Nefkens Prize for Cancer Research (Erasmus MC, Rotterdam) 2008 Meyenburg Cancer Research Award, Germany 2009 The Queen Wilhelmina Dutch Cancer Society Award, Amsterdam 2010 The United European Gastroenterology Federation (UEGF) Research Prize 2011 The Ernst Jung Medical Award, Germany 2011 Kolff prize, Amsterdam 2012 Association pour la Recherche sur le Cancer (ARC) Léopold Griffuel Prize, Paris 2012 William Beaumont prize of the American Gastroenterology Association 2012 The Heineken Prize for Medicine 2012 Knight in the Order of the Netherlands’ Lion 2013 The Breakthrough Prize in Life Sciences 2013 International Dream Team (with Hans Bos) by Dutch Cancer Society (KWF) 2014 Massachusetts General Hospital Award in Cancer Research 2014 TEFAF Oncology Chair 2014, Maastricht 2014 Fellow of the AACR Academy 2014 Struyvenberg European Society for Clinical Investigation (ESCI) medal 2014 National Icon of the Netherlands 2015 ISSCR-McEwen Award for Innovation 2016 The Academy Professor Prize of the Royal Netherlands Academy 2016 Kazemi Award for Research Excellence in Bio-Medicine 2016 The Körber European Science Prize, Germany 2016 Swammerdam medal, Amsterdam 2016 The Ilse & Helmut Wachter award, Hamburg, Germany 2017 Princess Takamatsu Award of Merit, Tokyo 2018 Großes Verdienstkreuz mit Stern, Germany 2018 Academia Europaea Erasmus Medal, Barcelona, Spain 2019 Honorary Fellow of the Royal Society of Edinburgh (UK) 2019 Keio Medical Science Prize of the Keio University (Japan) 2019 Citation Laureate, Web of Science Group 2021 Pezcoller Foundation-AACR International Award 2022 Ammodo Science Award
Prize juries
2008 – 2015 Louis Jeantet Prize, Geneva 2013 – 2015 Canada Gairdner Award, Toronto 2014 – Breakthrough Prize in Life Sciences, San Francisco 2015 Pezcoller Foundation – AACR International Award for Cancer Research, Italy 2015 Dr. Paul Janssen Award, Bruxelles 2017 – Francqui Prize, Bruxelles 2017 – Shaw Prize, Hong Kong 2017 Kovalenko Medal, National Academy of Sciences Washington 2021 Chair Cancer Research Committee of AACR Award for Lifetime Achievement, US 2022 – World Laureates Association Prize
Honorary Professorships
2002 – Central South University, Chang Sha, China 2014 – 2015 TEFAF Oncology Chair, Maastricht 2015 – 2016 Visiting professor, Weizmann Institute, Rehovoth, Israel 2016 – Distinguished Visiting Professor, University of Hong Kong 2015 Visiting professor, University of Melbourne, Australia 2019 – Honorary Director, Fudan Organoid Center, Fudan University, Shanghai 2021 Honorary Doctorate Catholic University of Leuven, Belgium
Elected Memberships
1999 Member European Molecular Biology Organisation (EMBO) 2000 Member of the Royal Netherlands Academy of Sciences (KNAW) 2009 Member of the Academia Europaea 2012 Member of the American Academy of Arts and Sciences 2012 Member of the Royal Netherlands Society of Sciences and Humanities 2014 Member of the National Academy of Sciences of the USA 2016 Member of the Academie des Sciences de I’Institut de France 2017 Member of the Orden Pour le Mérite für Wissenschaften und Künste, Germany 2019 Foreign Member of the Royal Society, London, United Kingdom 2019 Honorary Fellow of the Royal Society of Edinburgh, Scotland 2019 Honorary Fellowship of the Royal Society of Edinburgh, Scotland’s National Academy of Science and Letters
Advisory Boards
2005 – 2015 Member Scientific Advisory Board of Swiss Institute for Experimental Cancer Research, Lausanne 2006 – 2008 President of the International Society of Differentiation (ISD) 2007 – 2010 Member of the National Scientific Advisory Board NKI-AVL, Amsterdam 2012 – 2015 Member of the Board of the American Association of Cancer Research 2015 – 2021 Member of the Scientific Advisory Board of the Institute of Molecular Pathology, Vienna 2016 – 2020 Member of the Scientific Advisory Board of Kallyope, New York 2016 – Member of the Scientific Advisory Board of the Francis Crick Institute, London 2016 – 2021 Member of the Scientific Advisory Board of Decibel Therapeutics, Boston 2016 – 2022 Member of the Scientific Advisory Board of Surrozen, San Francisco 2017 – 2018 President of the International Society for Stem Cell Research (ISSCR) 2018 – 2021 Member of the Scientific Advisory Board of Merus, Utrecht 2018 – 2022 Scientific advisor Life Science Partners, Amsterdam 2019 – 2022 Non-executive member of the Board of Directors of Roche Holding Ltd, Basel 2020 – 2021 Member of the Scientific Advisory Board of Volestra Therapeutic Inc., New York 2020 – 2022 Chair of the Scientific Advisory Board DImed Inc., Shanghai 2020 – 2022 Chair of the Scientific Advisory Board of Xilis, at Duke University (NC)
Disclosures
Unsalaried advisory positions
Hans Clevers is advisor/guest researcher at the Hubrecht Institute and the Princess Máxima Center for Pediatric Oncology and Oncode Investigator, all in Utrecht, NL. He also is University Professor at Utrecht University.
Clevers is inventor on multiple organoid patents, licensed by the KNAW to the Foundation HUB in Utrecht. He holds stock in several biotech companies based on prior Scientific Advisory Board positions, notably Xilis, Kallyope and Surrozen in the USA, and D1Med in China
He also fills rotating positions in international ‘Learned Societies’ (e.g. ISSCR, AACR), Award Juries (e.g. Francqui Prize, Brussels; Breakthrough Prize, San Francisco, WLA Prize, Shanghai) and in Scientific Advisory Boards (SABs) of the Crick Institute in London).
Current position Since March 2022, Hans Clevers is Head of pharma Research and Early Development (pRED) of Roche, Basel Switzerland.
Curriculum Vitae
Twitter
Group Twitter
ResearchGate
Contact
Laboratory website
advisorguestresearcher
actinggroupleader
Technician
Postdoc
PhD Student
Guest
Show all group members